A phase I study of intravesical camrelizumab for BCG failure Non-Muscle Invasive Bladder Cancer (NMIBC)

被引：0
|
作者：
Wang, Y. [1 ]
Xu, P. H. [1 ]
Bian, X. J. [1 ]
Lu, X. L. [1 ]
Wang, Z. [2 ]
Wang, X. [3 ]
Yao, X. D. [4 ]
Shen, Y. J. [1 ]
Ye, D. Y. [1 ]
机构：
[1] Fudan Univ, Shanghai Canc Ctr, Dept Urol, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Shanghai Ninth Peoples Hosp, Sch Med, Dept Urol, Shanghai, Peoples R China
[3] Shanghai Jiao Tong Univ, Sch Med, Dept Urol, Shanghai Gen Hosp, Shanghai, Peoples R China
[4] Shanghai Tong Ji Univ, Sch Med, Dept Urol, Shanghai Tenth Peoples Hosp, Shanghai, Peoples R China
来源：
EUROPEAN UROLOGY | 2022年 / 81卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A0161
引用
收藏
页码：S251 / S251
页数：1
相关论文
共 50 条
  • [21] Intravesical gemcitabine for non-muscle invasive bladder cancer
    Jones, Gabriel
    Cleves, Anne
    Wilt, Timothy J.
    Mason, Malcolm
    Kynaston, Howard G.
    Shelley, Mike
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (01):
  • [22] Intravesical Gemcitabine for non-muscle invasive Bladder Cancer
    Krabbe, L. -M.
    Schmidt, S.
    UROLOGE, 2015, 54 (03): : 402 - 405
  • [23] REAL-WORLD EFFICACY OF ADJUVANT INTRAVESICAL GEMCITABINE FOR NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
    Abou, Chakra Mohamad
    Vignesh, Packiam T.
    Michael, O'Donnell A.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 : S54 - S54
  • [24] NON-MUSCLE INVASIVE BLADDER CANCER RESISTANT TO BCG
    Turker, Polat
    Turkeri, Levent
    ARCHIVOS ESPANOLES DE UROLOGIA, 2013, 66 (09): : 833 - 840
  • [25] Transforming non-muscle invasive bladder cancer (NMIBC) treatment: FDA approval of Anktiva in combination with BCG
    Khattak, Aimal Alam
    Javed, Ahmed
    Pokhrel, Prakriti
    Mukhtar, Sameen
    ANNALS OF MEDICINE AND SURGERY, 2025, 87 (02): : 457 - 459
  • [26] IS INTRAVESICAL BCG ALONE STILL THE ONLY TRULY EFFECTIVE INTRAVESICAL THERAPY FOR NON-MUSCLE INVASIVE BLADDER CANCER?
    Di Stasi, Savino Mauro
    Riedl, Claus
    Giannantoni, Antonella
    Verri, Cristian
    Celestino, Francesco
    De Carlo, Francesco
    Masedu, Francesco
    Valenti, Marco
    JOURNAL OF UROLOGY, 2015, 193 (04): : E381 - E381
  • [27] Analysis of inflammatory response during intravesical immunotherapy with BCG for non-muscle invasive bladder cancer
    Takeda, Yuji
    Kato, Tomoyuki
    Naito, Sei
    Ito, Hiromi
    Ushijima, Masaki
    Narisawa, Takafumi
    Kanno, Hidenori
    Kurota, Yuta
    Tsuchiya, Norihiko
    Asao, Hironobu
    CANCER SCIENCE, 2021, 112 : 841 - 841
  • [28] Intravesical BCG induces a trained immunity phenotype in patients with non-muscle invasive bladder cancer
    van Puffelen, J. H.
    Novakovic, B.
    Van Emst, L.
    Boormans, J. L.
    Oosterwijk, E.
    Van der Heijden, A. G.
    Netea, M. G.
    Joosten, L. A. B.
    Vermeulen, S. H.
    EUROPEAN UROLOGY, 2021, 79 : S615 - S616
  • [29] HRQOL IN PATIENTS UNDERWENT INTRAVESICAL INSTILLATION OF BCG OR MMC FOR NON-MUSCLE INVASIVE BLADDER CANCER
    Siracusano, Salvatore
    Silvestri, Tommaso
    Ciciliato, Stefano
    Toffoli, Laura
    Visalli, Francesco
    Di Cosmo, Giacomo
    Talamini, Renato
    JOURNAL OF UROLOGY, 2016, 195 (04): : E134 - E135
  • [30] Chest wall tumor following intravesical BCG instillation for non-muscle invasive bladder cancer
    Hartert, Marc
    Deppe, Claudia
    Fink, Ludger
    Kappes, Jutta
    JOURNAL OF CLINICAL TUBERCULOSIS AND OTHER MYCOBACTERIAL DISEASES, 2024, 35
12345